Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Aganirsen

EU orphan designation number: EU/3/14/1275   
Active ingredient: Aganirsen
Indication: Treatment of central retinal vein occlusion
Sponsor: Gene Signal SAS
4 rue Pierre Fontaine, 91000 Evry, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/06/2014 Orphan designation EMA/OD/008/14 (2014)3992 of 10/06/2014